Sun Life Receives Regulatory Approval of Normal Course Issuer Bid Renewal
Sun Life (TSX: SLF, NYSE: SLF) received OSFI and TSX approval to renew its normal course issuer bid to repurchase up to 10,000,000 common shares, about 1.8% of shares outstanding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Sun Life (TSX: SLF, NYSE: SLF) received OSFI and TSX approval to renew its normal course issuer bid to repurchase up to 10,000,000 common shares, about 1.8% of shares outstanding.
The NCIB runs from May 29, 2026 to May 28, 2027, with an automatic repurchase plan and a TSX daily cap of 502,034 shares. The prior NCIB was fully used, buying 10,570,915 shares at a weighted average of $83.33.
Positive
- Regulatory approval to repurchase up to 10,000,000 common shares (about 1.8% of float)
- NCIB period from May 29, 2026 to May 28, 2027 adds capital-return flexibility
- TSX daily purchase limit of 502,034 shares (25% of 2,008,137 ADTV)
- Prior NCIB fully utilized with 10,570,915 shares repurchased at $83.33 average price
- Automatic repurchase plan enables buybacks during blackout and restricted trading periods
Negative
- None.
Details
News Market Reaction – SLF
On May 27, the first trading day after this news, SLF closed 0.58% below the previous close.
Data tracked by StockTitan Argus for the May 27 session.
Key Figures
- NCIB size
- 10,000,000 common shares
- Maximum shares under renewed NCIB
- NCIB percentage
- 1.8% of common shares
- Portion of 554,255,267 shares outstanding as of May 15, 2026
- Shares outstanding
- 554,255,267 common shares
- Issued and outstanding as at May 15, 2026
- NCIB period
- May 29, 2026 to May 28, 2027
- Planned duration of renewed NCIB
- ADTV (TSX)
- 2,008,137 common shares
- Average daily trading volume for six months ending Apr 30, 2026
- Daily buy limit (TSX)
- 502,034 common shares
- 25% of ADTV allowed per trading day under TSX rules
- Prior NCIB capacity
- 10,570,915 common shares
- Maximum under Prior NCIB from Jun 9, 2025 to May 21, 2026
- Prior NCIB avg price
- $83.33 per share
- Weighted average price paid for 10,570,915 shares under Prior NCIB
Historical Context
-
Released analysis of 70,000+ high-cost medical claims for employers.
-
All 13 director nominees elected with 97.9–99.8% shareholder support.
-
Chief Legal and Public Policy Officer received a legal profession achievement award.
-
Raised common dividend to $0.96 per share and declared preferred dividends.
-
Announced intention to renew NCIB for up to 10,000,000 common shares.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
normal course issuer bid regulatory
automatic repurchase plan financial
insider trading rules regulatory
block purchases financial
issuer bid exemption orders regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
The NCIB will provide the Company with the flexibility to acquire common shares in order to return capital to shareholders as part of its overall capital management strategy.
The NCIB will commence on May 29, 2026 and continue until May 28, 2027, or such earlier date as the Company may determine. The average daily trading volume on the TSX for the six months ending April 30, 2026 was 2,008,137 common shares (the "ADTV"). Purchases under the NCIB may be made through the facilities of the TSX, other Canadian stock exchanges, the New York Stock Exchange (the "NYSE") and/or alternative trading platforms in
Subject to regulatory approval, purchases under the NCIB may also be made by way of private agreements or share repurchase programs under issuer bid exemption orders issued by securities regulatory authorities. Any purchases made under an exemption order issued by a securities regulatory authority will generally be at a discount to the prevailing market price. The actual number of common shares purchased under the NCIB, and the timing of such purchases (if any), will be determined by the Company. Any common shares purchased by the Company pursuant to the NCIB will be cancelled or used in connection with certain equity settled incentive arrangements.
The Company has established an automatic repurchase plan with its designated broker in order to facilitate purchases of common shares under the NCIB. Under the automatic repurchase plan, the Company's designated broker may purchase common shares pursuant to the NCIB at times when the Company ordinarily would not be active in the market due to its own internal trading blackout periods, insider trading rules or otherwise. Purchases made pursuant to the automatic repurchase plan, if any, will be made by the Company's designated broker based upon the parameters prescribed by the TSX, the NYSE, applicable Canadian and
Under its prior normal course issuer bid (the "Prior NCIB"), which commenced on June 9, 2025 and expired on May 21, 2026, the Company was permitted to purchase up to 10,570,915 common shares. As of May 15, 2026, the Company had purchased 10,570,915 common shares under the Prior NCIB at a weighted average price of
Forward-Looking Statements
From time to time, the Company makes written or oral forward-looking statements within the meaning of certain securities laws, including the "safe harbour" provisions of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements contained in this news release include statements (i) relating to the NCIB (including, but not limited to, statements regarding future purchases of common shares under the NCIB, including under the automatic repurchase plan), (ii) that are predictive in nature or that depend upon or refer to future events or conditions, and (iii) that include words such as "intends", "expects", "will" and similar expressions. The forward-looking statements made in this news release are stated as at May 26, 2026, represent the Company's current expectations, estimates and projections regarding future events and are not historical facts. These statements are not a guarantee of future performance and involve assumptions and risks and uncertainties that are difficult to predict. Some of these assumptions and risks and uncertainties are described further in the Company's management's discussion and analysis for the year ended December 31, 2025 under the heading "Forward-looking Statements", in the risk factors set out in the Company's annual information form for the year ended December 31, 2025 under the heading "Risk Factors", and in the Company's interim management's discussion and analysis for the quarter ended March 31, 2026 under the heading "Risk Management", in the other factors detailed in the Company's annual and interim financial statements and in the Company's other filings with Canadian and
The Company does not undertake any obligation to update or revise its forward-looking statements to reflect events or circumstances after the date of this news release or to reflect the occurrence of unanticipated events, except as required by law.
About Sun Life
Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including
Sun Life Financial Inc. trades on the
Note to editors: All figures in Canadian dollars
To contact Sun Life media relations, please email Media.Relations@sunlife.com.
To contact Sun Life investor relations, please email Investor_Relations@sunlife.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/sun-life-receives-regulatory-approval-of-normal-course-issuer-bid-renewal-302782303.html
SOURCE Sun Life Financial Inc. - Financial News
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
